Vaccine Setback for AstraZeneca

AstraZeneca and Oxford University are leading COVID-19 vaccine trials. Recently, AstraZeneca paused its trials due to an unexplained illness in a participant, a routine step to ensure safety. Experts suggest such pauses are common and may not be linked to the vaccine. The halt could impact global vaccine development efforts, with over 170 vaccines in progress and 30 in human trials.

Which organizations are mentioned as leading the COVID-19 vaccine race?

• Sinovac and Bharat Biotech

• Pfizer and Moderna

• AstraZeneca and Oxford University

• Johnson & Johnson and Novavax

What was the reason for AstraZeneca halting its vaccine trial?

• A lack of funding

• An unexplained illness in a participant

• Completion of the trial phase

• Regulatory approval

Why are pauses in vaccine trials considered routine?

• To reduce costs

• To ensure safety and integrity

• To comply with government regulations

• To increase public interest

What is the significance of understanding the cause of the adverse event in the trial?

• To increase production speed

• To improve marketing strategies

• To gain public trust

• To ensure the vaccine's safety

How many vaccines are currently in human studies according to the transcript?

• More than 100

• More than 30

• More than 200

• More than 50